IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Medicxi Ventures Management (Jersey) Ltd

Q3 2024 Holdings

Filed 2024-10-15 | 4 holdings | $528.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$319.2M19,963,15760.4%
Phathom Pharmaceuticals Inc(PHAT)COM71722W107$135.0M7,464,57225.5%
Newamsterdam Pharma Company(NAMS)ORDINARY SHARESN62509109$47.6M2,869,5659.0%
Aura Biosciences Inc(AURA)COM05153U107$27.1M3,039,8925.1%